ATE189771T1 - Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält - Google Patents

Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält

Info

Publication number: ATE189771T1
Authority: AT; Austria
Prior art keywords: morphine; controlled release; preparations; manufacture; preparation containing
Prior art date: 1993-03-30

Application number

AT94912116T

Other languages

English (en)

Inventor

Birgitta Olsson

Maritta Anneli Chefrad

Gert Ragnarsson

Original Assignee

Pharmacia & Upjohn Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-30

Filing date

1994-03-24

Publication date

2000-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20389415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE189771(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-03-24 Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab

2000-03-15 Application granted granted Critical

2000-03-15 Publication of ATE189771T1 publication Critical patent/ATE189771T1/de

Links

BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical class O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title abstract 9
239000003405 delayed action preparation Substances 0.000 title 1
229960005181 morphine Drugs 0.000 abstract 4
238000002360 preparation method Methods 0.000 abstract 3
238000004519 manufacturing process Methods 0.000 abstract 2
210000002966 serum Anatomy 0.000 abstract 2
230000000202 analgesic effect Effects 0.000 abstract 1
230000004888 barrier function Effects 0.000 abstract 1
239000002775 capsule Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
230000036470 plasma concentration Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT94912116T 1993-03-30 1994-03-24 Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält ATE189771T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9301057A SE9301057L (sv)	1993-03-30	1993-03-30	Beredning med kontrollerad frisättning
PCT/SE1994/000264 WO1994022431A1 (en)	1993-03-30	1994-03-24	Controlled release preparation containing a salt of morphine

Publications (1)

Publication Number	Publication Date
ATE189771T1 true ATE189771T1 (de)	2000-03-15

Family

ID=20389415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94912116T ATE189771T1 (de)	1993-03-30	1994-03-24	Zubereitung mit kontrollierter freisetzung, die ein morphinsalz enthält

Country Status (25)

Country	Link
US (1)	US5614218A (de)
EP (1)	EP0642335B2 (de)
JP (1)	JP4107678B2 (de)
KR (1)	KR100316206B1 (de)
CN (1)	CN1104891C (de)
AT (1)	ATE189771T1 (de)
AU (1)	AU680891C (de)
CA (1)	CA2135639C (de)
CZ (1)	CZ284924B6 (de)
DE (1)	DE69423028T3 (de)
DK (1)	DK0642335T4 (de)
EE (1)	EE03147B1 (de)
ES (1)	ES2144516T5 (de)
FI (1)	FI113743B (de)
GR (1)	GR3033325T3 (de)
HU (1)	HU227344B1 (de)
LV (1)	LV10684B (de)
NO (1)	NO310015B1 (de)
NZ (1)	NZ263632A (de)
PL (1)	PL175326B1 (de)
PT (1)	PT642335E (de)
RU (1)	RU2136283C1 (de)
SE (1)	SE9301057L (de)
SK (1)	SK280362B6 (de)
WO (1)	WO1994022431A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5266331A (en) *	1991-11-27	1993-11-30	Euroceltique, S.A.	Controlled release oxycodone compositions
US5968551A (en)	1991-12-24	1999-10-19	Purdue Pharma L.P.	Orally administrable opioid formulations having extended duration of effect
US5472712A (en) *	1991-12-24	1995-12-05	Euroceltique, S.A.	Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5478577A (en) *	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5958459A (en) *	1991-12-24	1999-09-28	Purdue Pharma L.P.	Opioid formulations having extended controlled released
AU735113C (en) *	1991-12-24	2007-06-14	Mundipharma Medical Gmbh	Opioid formulations for treating pain
US20080075781A1 (en) *	1992-11-25	2008-03-27	Purdue Pharma Lp	Controlled release oxycodone compositions
IL119660A (en) *	1993-05-10	2002-09-12	Euro Celtique Sa	Controlled release formulation comprising tramadol
US20070275062A1 (en) *	1993-06-18	2007-11-29	Benjamin Oshlack	Controlled release oxycodone compositions
US7740881B1 (en)	1993-07-01	2010-06-22	Purdue Pharma Lp	Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) *	1993-07-01	1999-11-30	Euro Celtique Sa	Solid controlled-release oral dosage forms of opioid analgesics
IL109944A (en) †	1993-07-01	1998-12-06	Euro Celtique Sa	Sustained release dosage unit forms containing morphine and a method of preparing these sustained release dosage unit forms
US5879705A (en) *	1993-07-27	1999-03-09	Euro-Celtique S.A.	Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) *	1993-11-23	1999-04-06	Euro-Celtique, S.A.	Pharmaceutical multiparticulates
US20020006438A1 (en) *	1998-09-25	2002-01-17	Benjamin Oshlack	Sustained release hydromorphone formulations exhibiting bimodal characteristics
US5965161A (en)	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
GB9519363D0 (en)	1995-09-22	1995-11-22	Euro Celtique Sa	Pharmaceutical formulation
DE19607395C2 (de) *	1996-02-28	2002-11-21	Lohmann Therapie Syst Lts	Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
US6245351B1 (en)	1996-03-07	2001-06-12	Takeda Chemical Industries, Ltd.	Controlled-release composition
US5891474A (en)	1997-01-29	1999-04-06	Poli Industria Chimica, S.P.A.	Time-specific controlled release dosage formulations and method of preparing same
US6066339A (en) *	1997-10-17	2000-05-23	Elan Corporation, Plc	Oral morphine multiparticulate formulation
US6806294B2 (en)	1998-10-15	2004-10-19	Euro-Celtique S.A.	Opioid analgesic
DE19901683B4 (de) *	1999-01-18	2005-07-21	Grünenthal GmbH	Analgetikum mit kontrollierter Wirkstofffreisetzung
FR2794646B1 (fr)	1999-06-09	2001-09-21	Ethypharm Lab Prod Ethiques	Microgranules de sulfate de morphine, procede de preparation et composition les contenant
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
KR20020059653A (ko)	1999-10-29	2002-07-13	그린 마틴, 브라이언 쥐 테슬리	서방성 하이드로코돈 제형
EP1337244A4 (de)	2000-10-30	2006-01-11	Euro Celtique Sa	Hydrocodon-formulierungen mit kontrollierter freisetzung
UA81224C2 (uk) *	2001-05-02	2007-12-25	Euro Celtic S A	Дозована форма оксикодону та її застосування
US20110104214A1 (en)	2004-04-15	2011-05-05	Purdue Pharma L.P.	Once-a-day oxycodone formulations
US20030070584A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
AU4061702A (en) *	2001-05-15	2003-04-03	Mcneil-Ppc, Inc.	Dip coating compositions containing starch or dextrin
US20030072731A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing starch or dextrin
US20040234602A1 (en)	2001-09-21	2004-11-25	Gina Fischer	Polymer release system
WO2003024430A1 (en)	2001-09-21	2003-03-27	Egalet A/S	Morphine polymer release system
US8309118B2 (en) *	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
PT1485078E (pt) *	2002-03-15	2013-01-14	Cypress Bioscience Inc	Milnacipran para o tratamento do síndrome do intestino irritável
US7429619B2 (en) *	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
AU2003270778B2 (en) *	2002-09-20	2009-10-08	Alpharma Pharmaceuticals, Llc	Sequestering subunit and related compositions and methods
US20050020613A1 (en) *	2002-09-20	2005-01-27	Alpharma, Inc.	Sustained release opioid formulations and method of use
BR0314526A (pt) *	2002-10-04	2005-07-26	Pharmacia Corp	Composições farmacêuticas para o tratamento do mal de parkinson
US20060003004A1 (en) *	2002-10-25	2006-01-05	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
US20040132826A1 (en) *	2002-10-25	2004-07-08	Collegium Pharmaceutical, Inc.	Modified release compositions of milnacipran
EP1592453A1 (de) *	2003-01-28	2005-11-09	Collegium Pharmaceutical, Inc.	Multiparticulate aufbau von milnacipran für orale einnahme
ES2360102T3 (es)	2003-03-26	2011-05-31	Egalet A/S	Sistema para la liberación controlada de morfina.
TWI347201B (en) *	2003-04-21	2011-08-21	Euro Celtique Sa	Pharmaceutical products,uses thereof and methods for preparing the same
PT1575565E (pt) *	2003-08-08	2010-03-03	Biovail Lab Int Srl	Comprimido de libertação modificada de cloridrato de bupropiona
EP1810678A1 (de)	2006-01-19	2007-07-25	Holger Lars Hermann	Verwendung einer Kombination von Morphin und Naloxon zur Drogensubstitution
US20070190141A1 (en) *	2006-02-16	2007-08-16	Aaron Dely	Extended release opiate composition
US20080069891A1 (en) *	2006-09-15	2008-03-20	Cima Labs, Inc.	Abuse resistant drug formulation
US20080069871A1 (en) *	2006-07-21	2008-03-20	Vaughn Jason M	Hydrophobic abuse deterrent delivery system
US8445018B2 (en)	2006-09-15	2013-05-21	Cima Labs Inc.	Abuse resistant drug formulation
WO2008148798A2 (en)	2007-06-04	2008-12-11	Egalet A/S	Controlled release pharmaceutical compositions for prolonged effect
WO2009023672A2 (en) *	2007-08-13	2009-02-19	Abuse Deterrent Pharmaceutical Llc	Abuse resistant drugs, method of use and method of making
GB2460915B (en) *	2008-06-16	2011-05-25	Biovascular Inc	Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
NZ594207A (en)	2009-02-06	2013-03-28	Egalet Ltd	Immediate release composition resistant to abuse by intake of alcohol
WO2010099508A1 (en)	2009-02-26	2010-09-02	Theraquest Biosciences, Inc.	Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
AU2010265213B2 (en)	2009-06-24	2012-08-23	Egalet Ltd.	Controlled release formulations
EP2568977A1 (de)	2010-05-11	2013-03-20	Cima Labs Inc.	Alkoholresistente metoprololhaltige orale retard-dosierformen
EP2590636A1 (de)	2010-07-06	2013-05-15	Grünenthal GmbH	Neue gastroretentive dosierungsformen mit einem gaba-analog und einem opioid
BR112015000150A2 (pt)	2012-07-06	2017-06-27	Egalet Ltd	composições farmacêuticas dissuasoras de abuso de liberação controlada
US11571390B2 (en)	2013-03-15	2023-02-07	Othemo Life Sciences, Inc.	Abuse deterrent compositions and methods of use
CA3042642A1 (en)	2013-08-12	2015-02-19	Pharmaceutical Manufacturing Research Services, Inc.	Extruded immediate release abuse deterrent pill
US9492444B2 (en)	2013-12-17	2016-11-15	Pharmaceutical Manufacturing Research Services, Inc.	Extruded extended release abuse deterrent pill
WO2015095391A1 (en)	2013-12-17	2015-06-25	Pharmaceutical Manufacturing Research Services, Inc.	Extruded extended release abuse deterrent pill
ES2809458T3 (es)	2014-07-17	2021-03-04	Pharmaceutical Manufacturing Res Services Inc	Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata
US10729685B2 (en)	2014-09-15	2020-08-04	Ohemo Life Sciences Inc.	Orally administrable compositions and methods of deterring abuse by intranasal administration
EP3209282A4 (de)	2014-10-20	2018-05-23	Pharmaceutical Manufacturing Research Services, Inc.	Missbrauchssichere flüssigkeitsfülldosierform mit verlängerter freisetzung
WO2019126125A1 (en)	2017-12-20	2019-06-27	Purdue Pharma L.P.	Abuse deterrent morphine sulfate dosage forms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4443428A (en) *	1982-06-21	1984-04-17	Euroceltique, S.A.	Extended action controlled release compositions
CA2007181C (en) *	1989-01-06	1998-11-24	Angelo Mario Morella	Sustained release pharmaceutical composition
SE8902699D0 (sv) *	1989-08-09	1989-08-09	Lejus Medical Ab	Diltiazem containing pharmaceutical compositios
DE4105480A1 (de) *	1991-02-21	1992-08-27	Boehringer Mannheim Gmbh	Verbesserte aktivierung von rekombinanten proteinen
US5478577A (en) †	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5273760A (en) †	1991-12-24	1993-12-28	Euroceltigue, S.A.	Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
SE9202250D0 (sv) *	1992-07-29	1992-07-29	Gacell Lab Ab	Controlled release morphine preparation

1993
- 1993-03-30 SE SE9301057A patent/SE9301057L/xx not_active Application Discontinuation
1994
- 1994-03-16 US US08/213,518 patent/US5614218A/en not_active Expired - Lifetime
- 1994-03-24 ES ES94912116T patent/ES2144516T5/es not_active Expired - Lifetime
- 1994-03-24 CN CN94190160A patent/CN1104891C/zh not_active Expired - Lifetime
- 1994-03-24 WO PCT/SE1994/000264 patent/WO1994022431A1/en not_active Ceased
- 1994-03-24 CA CA002135639A patent/CA2135639C/en not_active Expired - Lifetime
- 1994-03-24 PL PL94306421A patent/PL175326B1/pl unknown
- 1994-03-24 RU RU94046147A patent/RU2136283C1/ru active
- 1994-03-24 DK DK94912116T patent/DK0642335T4/da active
- 1994-03-24 NZ NZ263632A patent/NZ263632A/en not_active IP Right Cessation
- 1994-03-24 DE DE69423028T patent/DE69423028T3/de not_active Expired - Lifetime
- 1994-03-24 PT PT94912116T patent/PT642335E/pt unknown
- 1994-03-24 CZ CZ942986A patent/CZ284924B6/cs not_active IP Right Cessation
- 1994-03-24 JP JP52197694A patent/JP4107678B2/ja not_active Expired - Lifetime
- 1994-03-24 AU AU64393/94A patent/AU680891C/en not_active Expired
- 1994-03-24 HU HU9403437A patent/HU227344B1/hu unknown
- 1994-03-24 AT AT94912116T patent/ATE189771T1/de active
- 1994-03-24 SK SK1437-94A patent/SK280362B6/sk not_active IP Right Cessation
- 1994-03-24 KR KR1019940704397A patent/KR100316206B1/ko not_active Expired - Lifetime
- 1994-03-24 EP EP94912116A patent/EP0642335B2/de not_active Expired - Lifetime
- 1994-11-16 EE EE9400376A patent/EE03147B1/xx unknown
- 1994-11-29 NO NO944565A patent/NO310015B1/no not_active IP Right Cessation
- 1994-11-29 FI FI945621A patent/FI113743B/fi not_active IP Right Cessation
- 1994-11-30 LV LVP-94-228A patent/LV10684B/xx unknown
2000
- 2000-04-26 GR GR20000401009T patent/GR3033325T3/el unknown

Also Published As

Publication number	Publication date
EP0642335B2 (de)	2005-01-19
SK143794A3 (en)	1995-06-07
SE9301057L (sv)	1994-10-01
RU2136283C1 (ru)	1999-09-10
CZ284924B6 (cs)	1999-04-14
CA2135639A1 (en)	1994-10-13
NO944565D0 (no)	1994-11-29
NO944565L (no)	1994-11-29
NZ263632A (en)	1997-06-24
DK0642335T3 (da)	2000-07-24
DE69423028T3 (de)	2006-07-20
CA2135639C (en)	2006-02-07
FI945621A0 (fi)	1994-11-29
FI113743B (fi)	2004-06-15
FI945621L (fi)	1994-11-29
AU680891C (en)	2002-01-03
CN1104891C (zh)	2003-04-09
SE9301057D0 (sv)	1993-03-30
HUT71417A (en)	1995-11-28
EP0642335A1 (de)	1995-03-15
SK280362B6 (sk)	1999-12-10
AU680891B2 (en)	1997-08-14
WO1994022431A1 (en)	1994-10-13
HU227344B1 (en)	2011-04-28
CZ298694A3 (en)	1995-05-17
JP4107678B2 (ja)	2008-06-25
ES2144516T3 (es)	2000-06-16
AU6439394A (en)	1994-10-24
HU9403437D0 (en)	1995-02-28
DK0642335T4 (da)	2005-05-23
DE69423028T2 (de)	2001-01-18
PT642335E (pt)	2000-08-31
JPH08501319A (ja)	1996-02-13
US5614218A (en)	1997-03-25
PL306421A1 (en)	1995-04-03
ES2144516T5 (es)	2005-07-01
LV10684B (en)	1996-02-20
PL175326B1 (pl)	1998-12-31
NO310015B1 (no)	2001-05-07
KR100316206B1 (ko)	2002-11-09
EP0642335B1 (de)	2000-02-16
RU94046147A (ru)	1996-11-10
GR3033325T3 (en)	2000-09-29
CN1106608A (zh)	1995-08-09
DE69423028D1 (de)	2000-03-23
EE03147B1 (et)	1999-02-15
LV10684A (lv)	1995-06-20

Legal Events

Date

Code

Title

Description

2000-08-15

UEP

Publication of translation of european patent specification

2005-06-15

EEFA

Change of the company name

2005-10-15

UEP